Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
Functional electrical stimulation through direct 4-channel nerve stimulation to improve gait in multiple sclerosis: a feasibility study.
A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
[Thoughts on hot issues of neuromyelitis optica].
Third ventricular enlargement in early stages of multiple sclerosis is a predictor of motor and neuropsychological deficits: a cross-sectional study.
The Central Role of Neuroscientists under National Socialism.
Effect of spasticity on kinematics of gait and muscular activation in people with Multiple Sclerosis.
Hypersensitivity Responses in the Central Nervous System.
Helminth/Parasite treatment of multiple sclerosis.
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
Estrogen treatment of experimental autoimmune encephalomyelitis requires E2 receptor positive B cells that upregulate PD-1 on CD4(+) Foxp3(+) Treg cells.
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
Experimental autoimmune encephalomyelitis.
Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis.
Multiple Sclerosis: Progress, but No Cure.
Osthole augments therapeutic efficiency of neural stem cells-based therapy in experimental autoimmune encephalomyelitis.
Effect of a self-management and follow-up program on self-efficacy in patients with multiple sclerosis: a randomized clinical trial.
Analysis of Neurogenesis during Experimental Autoimmune Encephalomyelitis Reveals Pitfalls of Bioluminescence Imaging.
Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics.
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.
The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.
Pages
« first
‹ previous
…
587
588
589
590
591
592
593
594
595
…
next ›
last »